To evaluate the role of a therapeutic regimen with plasma exchange, intravenous immunoglobulins and rituximab in chronic-active antibody-mediated rejection (cAMR) settings.
Treatment with plasmapheresis, immunoglobulins and rituximab for chronic-active antibody-mediated rejection in kidney transplantation: Clinical, immunological and pathological results
Mella, Alberto;Gallo, Ester;Messina, Maria;Caorsi, Cristiana;Amoroso, Antonio;Gontero, Paolo;Maletta, Francesca;Barreca, Antonella;Fop, Fabrizio;Biancone, Luigi
Last
2018-01-01
Abstract
To evaluate the role of a therapeutic regimen with plasma exchange, intravenous immunoglobulins and rituximab in chronic-active antibody-mediated rejection (cAMR) settings.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
